Molecular diagnostics in monogenic and multifactorial forms of Type 2 diabetes

Expert Review of Molecular Diagnostics

Volumn 1, Issue 4, 2001, Pages 403-412

  McCarthy, Mark I ^a   Hattersley, Andrew T ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Association; Linkage; MODY; Multifactorial disease; Type 2 diabetes

Indexed keywords

GENE IDENTIFICATION; GENE TARGETING; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; INDIVIDUALIZATION; MONOGENIC DISORDER; MULTIFACTORIAL INHERITANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; REVIEW; RISK FACTOR;

EID: 0035557623     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737159.1.4.403     Document Type: Review

References (59)

1. The dysmetabolic syndrome
2. The perils of portliness: Causes and consequences of visceral adiposity
3. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS33)
4. The genetics of Type 2 diabetes
5. Mild familial diabetes with dominant inheritance
6. Maturity-onset diabetes of the young: Clinical heterogeneity explained by genetic heterogeneity
7. Maturity onset-type diabetes of the young (MODY): One condition or many?
8. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus
9. Linkage of Type 2 diabetes to the glucokinase gene
10. Mutations in the hepatic nuclear factor 1 alpha gene in maturity-onset diabetes of the young (MODY3)
11. Mutations in the hepatocyce nuclear factor 4 α gene in maturity-onset diabetes of the young (MODY1)
12. Mutation in hepatocyte nuclear factor-1β gene TCF2 associated with MODY
13. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1
14. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus
15. Clinical characteristics of subjects with a missense mutation in glucokinase
16. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations
17. Hyperexcitability to sulphonylurea in MODY3
18. Sensitivity to sulfonylureas in patients with hepatocyte nuclear factor 1 α gene mutations: Evidence for pharmacogenetics in diabetes
19. HNF1 α controls renal glucose reabsorption in mouse and man
20. Mutation in the HNF-4 α gene affects insulin secretion and triglyceride metabolism
21. Abnormal nephron development associated with a frameshift mutation in the transcription factor HNF-1β
22. Mutations in the HNF1-β gene are associated with familial hypoplastic glomerulocystic kidney disease
23. Beta-cell genes and diabetes: Quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor 1-α and glucokinase mutations
24. Mutations in the Hepatocyte nuclear factor 1 α gene are a common cause of maturity-onset diabetes of the young in the United Kingdom
25. Mutations in the Hepatocyte nuclear factor 1α Gene in MODY and Early-onset NIDDM: Evidence for a Mutational Hotspot in Exon 4
26. Predictive genetic testing in maturity-onset diabetes of the young (MODY)
27. Genetic testing in maturity onset diabetes of the young (MODY): A new challenge for the diabetic clinic
28. A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria
29. Mutations in the glucokinase gene of the fetus result in reduced birth weight
30. Influence of maternal and fetal glucokinase mutations in gestational diabetes
31. The genetics of Type 2 diabetes
32. Searching for genetic determinants in the new millennium
33. Initial sequencing and analysis of the human genome
34. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms
35. Linkage disequilibrium in the human genome
36. Pharmacogenetics and the practice of medicine
37. Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans
38. Multipoint quantitative-trait linkage analysis in general pedigrees
39. Genetic dissection of complex traits
40. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of Type 2 diabetes
41. Analysis of parent-offspring trios provides evidence for linkage and association between the insulin gene and Type 2 diabetes mediated exclusively through paternally transmitted class III variable number tandem repeat alleles
42. A genome-wide search for human non-insulin-dependent Type 2 diabetes genes reveals a major susceptibility locus on chromosome 2
43. Genetic variation in the gene encoding calpain-10 is associated with Type 2 diabetes mellitus
44. Guilt by association
45. A genome-wide scan for loci predisposing to Type 2 diabetes in a UK population (The Diabetes (UK) Warren 2 Repository): Analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q
46. An autosomal genomic scan for loci linked to Type II diabetes mellitus and body-mass index in Pima Indians
47. The Finland-United States Investigation of non-insulin-dependent diabetes mellitus genetics FUSION study. I. An autosomal genome scan for genes that predispose to Type 2 diabetes
48. Genome-wide linkage analysis of stature in multiple populations reveals several regions with evidence of linkage to adult height
49. Positional cloning moves from the perditional to traditional
50. The future of genetic studies of complex human diseases
51. Tackling common disease
52. Genetics of diabetic nephropathy
53. Are rare variants responsible for susceptibility to complex diseases?
54. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
55. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
56. Association studies of the calpain-10 gene with Type 2 diabetes mellitus in the United Kingdom
57. Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension
58. Maturity-onset diabetes of the young: From clinical description to molecular genetic characterization